Julia Frede
9PUBLICATIONS
57CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Sep 19, 2025
The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myeloma.Julia Frede, Julia C Poller, Kayleen Shi
|Jan 15, 2025
Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma.Johannes M Waldschmidt, Noori Sotudeh, Sankalp Arora
|Apr 11, 2024
Dual role of signaling pathways in myeloma requires cell type-specific targeting of ligand-receptor interactions.Pablo Hernandez-Lopez, Tushara Vijaykumar, Praveen Anand
|Jul 26, 2023
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering.Li Li, Vakul Mohanty, Jinzhuang Dou
|Jun 27, 2022
Regulatory Programs of B-cell Activation and Germinal Center Reaction Allow B-ALL Escape from CD19 CAR T-cell Therapy.Nam Gyu Im, Amy Guillaumet-Adkins, Megha Wal
Pageof 2
Frequent Collaborators
7 joint publications
Birgit Knoechel
6 joint publications
Jens G Lohr
4 joint publications
Praveen Anand
3 joint publications
Kenneth C Anderson
3 joint publications
Johannes M Waldschmidt
3 joint publications
Jake A Kloeber
2 joint publications
Amy Guillaumet-Adkins
2 joint publications
Anna Rogers
2 joint publications
Antonis Kokkalis
2 joint publications
Sayalee Potdar